Skip to main content

Table 2 Overall mean health and cost outcomes for the UK

From: Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

UK1

 

TIV/LAIV

QIV/QLAIV

Difference (TIV/LAIV vs QIV/QLAIV)

% Difference

Average influenza-related outcomes per season, n (95 % CI)

Cases

6,175,473 (5,348,157; 7,095,022)

6,086,718 (5,244,706; 6,981,581)

−88,755 (−153,607; −46,761)

−1.4 (−2.5; −0.8)

GP visits

1,477,243 (1,276,226; 1,698,398)

1,454,327 (1,249,078; 1,672,087)

−22,917 (−39,758; −12,127)

−1.6 (−2.7; −0.8)

ER visits

45,688 (39,471; 52,528)

44,979 (38,631; 51,714)

−709 (−1,230; −375)

−1.6 (−2.7; −0.8)

Hospitalizations

71,740 (62,217; 82,455)

70,690 (61,026; 81,103)

−1,050 (−1,824; −553)

−1.5 (−2.5; −0.8)

Deaths

5,366 (4,609; 6,207)

5,136 (4,372; 5,941)

−230 (−424; −107)

−4.3 (−7.5; −2.0)

Average costs per season, £ (95 % CI)

Vaccination

£142,869,897 (142,132,194; 143,838,565)

£173,690,646 (172,847,546; 174,801,973)

£30,820,749 (30,714,458; 30,964,151)

GP visits

£54,658,003 (47,220,348; 62,840,730)

£53,810,083 (46,215,893; 61,867,225)

-£847,920 (−1,471,032; −448,693)

ER visits

£6,167,872 (5,328,571; 7,091,250)

£6,072,188 (5,215,223; 6,981,395)

-£95,683 (−165,998; −50,633)

Hospitalization

£316,143,107 (273,230,094; 363,500,069)

£310,054,168 (266,192,382; 356,545,209)

-£6,088,939( −10,684,477; −3,156,736)

Total payer costs

£519,838,878 (469,625,943; 576,456,567)

£543,627,085 (491,853,288; 598,787,408)

£23,788,206 (18,451,500; 27,182,411)

Total costs, 2014–24: 3.5 % discount, £ (95 % CI)

Vaccination

£1,182,629,311 (1,176,522,193; 1,190,629,232)

£1,438,387,119 (1,431,392,398; 1,447,571,973)

£255,757,808 (254,873,033; 256,946,194)

GP visits

£449,966,551 (390,148,320; 516,657,013)

£442,621,741 (381,366,507; 508,088,148)

-£7,344,811 (−12,406,117; −3,925,542)

ER visits

£50,776,387 (44,026,211; 58,302,059)

£49,947,563 (43,035,229; 57,335,107)

-£828,824 (−1,399,966; −442,977)

Hospitalization

£2,603,109,409 (2,257,958,720; 2,989,825,442)

£2,550,795,544 (2,197,010,408; 2,929,281,052)

-£52,313,865 (−89,406,033; −26,864,867)

Total payer costs

£4,286,481,659 (3,871,840,486; 4,753,225,888)

£4,481,751,967 (4,063,534,469; 4,933,835,213)

£195,270,308 (152,116,034; 224,188,224)

QALYs lost, n (95 % CI)

Per season

138,681 (119,774; 159,443)

135,415 (116,128; 155,866)

−3,266 (−5,749; −1,616)

Total

1,143,215 (990,661; 1,314,381)

1,115,337 (958,023; 1,283,316)

−27,878 (−48,670; −13,753)

LYs lost, n (95 % CI)

Per season

67,761 (58,243; 78,145)

65,340 (55,700; 75,446)

−2,421 (−4,407; −1,150)

Total

560,869 (482,171; 647,615)

540,396 (459,999; 623,573)

−20,473 (−37,239; −9,741)

UK2

 

TIV/LAIV

QIV/QLAIV

Difference (TIV/LAIV vs QIV/QLAIV)

% Difference

Average influenza-related outcomes per season, n (95 % CI)

Cases

5,335,431 (4,663,367; 6,094,108)

5,237,644 (4,563,870; 5,976,162)

−97,787 (−167,789; −53,233)

−1.8 (−3.0; −1.0)

GP visits

1,279,954 (1,116,137; 1,463,587)

1,254,916 (1,091,268; 1,432,823)

−25,038 (−42,527; −13,756)

−2.0 (−3.2; −1.1)

ER visits

39,586 (34,520; 45,266)

38,812 (33,751; 44,314)

−774 (−1,315; −425)

−2.0 (−3.2; −1.1)

Hospitalizations

61,812 (54,111; 70,575)

60,658 (52,902; 69,153)

−1,154 (−1,992; −626)

−1.9 (−3.1; −1.1)

Deaths

4,772 (4,146; 5,483)

4,538 (3,921; 5,202)

−234 (−410; −116)

−4.9 (−8.3; −2.5)

Average costs per season, £ (95 % CI)

Vaccination

£171,724,730 (170,737,027; 172,880,105)

£202,522,845 (201,431,528; 203,801,765)

£30,798,116 (30,696,168; 30,920,847)

GP visits

£47,358,314 (41,297,066; 54,152,709)

£46,431,902 (40,376,915; 53,014,460)

-£926,412 (−1,573,508; −508,968)

ER visits

£5,344,140 (4,660,159; 6,110,852)

£5,239,599 (4,556,325; 5,982,406)

-£104,541 (−177,562; −57,434)

Hospitalization

£274,233,102 (239,080,248; 313,959,886)

£267,724,197 (232,618,317; 305,657,406)

-£6,508,906 (−11,183,958; −3,502,201)

Total payer costs

£498,660,286 (457,399,436; 545,711,073)

£521,918,543 (480,857,526; 567,317,462)

£23,258,257 (17,987,595; 26,732,485)

Total costs, 2014–24, 3.5 % discount, £ (95 % CI)

Vaccination

£1,421085,767 (1,412,898,941; 1,430,629,196)

£1,676,655,043 (1,667,605,341; 1,687,226,238)

£255,569,276 (254,720,544; 256,584,332)

GP visits

£390,019,191 (338,972,997; 445,806,414)

£382,011,087 (331,356,732; 436,393,837)

-£8,008,104 (−13,328,069; −4,445,418)

ER visits

£44,011,639 (38,251,341; 50,306,937)

£43,107,966 (37,391,885; 49,244,777)

-£903,673 (−1,504,003; −501,642)

Hospitalization

£2,258,890,346 (1,965,081,255; 2,581,768,165)

£2,203,039,151 (1,911,631,217; 2,513,877,596)

-£55,851,195 (−94,174,503; 30,373,049)

Total payer costs

£4,114,006,943 (3,771,593,455; 4,497,105,857)

£4,304,813,247 (3,962,279,878; 4,678,534,060)

£190,806,304 (147,019,450; 220,067,782)

QALYs lost, n (95 % CI)

Per season

121,040 (105,258; 138,570)

117,603 (102,122; 134,418)

−3,437 (−5,970; −1,802)

Total

998,215 (867,812; 1,140,983)

968,900 (839,411; 1,106,335)

−29,315 (−49,909; −15,593)

LYs lost, n (95 % CI)

Per season

59,931 (51,974; 68,794)

57,448 (49,677; 65,930)

−2,484 (−4,309; −1,247)

Total

496,291 (429,909; 568,923)

475,295 (409,468; 545,073)

−20,996 (−36,237; −10,647)

  1. Note: A negative value for the difference denotes outcomes prevented; GP, general practitioner; ER, emergency room; QALYs, quality-adjusted life years; LYs, life years